Patient Guide: A Study on the Safety, Efficacy and Immune Response Following Sequential Treatment With an Anti-sense Oligonucleotide Against Chronic Hepatitis B (CHB) and Chronic Hepatitis B Targeted Immunotherapy (CHB-TI) in CHB Patients Receiving Nucleos(t)Ide Analogue (NA) Therapy

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 51 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT05276297
Status: COMPLETED
Condition: Hepatitis B, Chronic
Phase: PHASE2

Find a Study Location Near You

This study is available at 51 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Edegem,
  • Sliven,
  • Sofia,
  • • And 48 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily